By Tony Schueth, CEO and Managing Partner
A new revolution is coming to the point of care. It leverages electronic prescribing (ePrescribing) to provide accurate, patient-specific information on medication prices and related out-of-pocket (OOP) costs at the point of prescribing. As described in our last blog on this topic, such actionable information will help reduce costs, improve medication adherence and outcomes and enhance patient and provider satisfaction. This blog describes recent advances and six opportunities for improvement.
Such information can be incorporated into the ePrescribing workflow so it is available at the point of prescribing. While this is an opportunity, there are challenges for EHR vendors. They must identify assistance programs, figure out how to integrate the information into their EHR and keep the information updated.
All of this is unknown to the provider at the point of care, who may have to ask about such very personal information — especially if the patient needs a very expensive drug with a very large copay, such as an oncology medication. Providers may be reluctant to have this discussion and patients likewise may be reluctant to provide such information and keep it available in the EHR.
These kinds of sensitive financial issues must be addressed going forward if drug price transparency at the point of care is to become an optimal tool for providers and consumers.
Moving forward. Considerable headway has been made to streamline processes, reduce costs and improve speed to therapy through advancements in drug price transparency at the point of prescribing. The RTBC will become a valuable tool to help ensure that patients will get the right, most cost-effective approved drug before they get to the pharmacy.
Keep current with Point-of-Care Partners. We are monitoring these developments and are active in the development of — and enhancements to – these and other standards related to ePrescribing. Drop me an email at firstname.lastname@example.org. I’d be happy to fill you in.